Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064495
Filing Date
2025-05-06
Accepted
2025-05-06 16:17:08
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20250331.htm   iXBRL 10-Q 2399996
2 EX-31.1 lyra-ex31_1.htm EX-31.1 17786
3 EX-31.2 lyra-ex31_2.htm EX-31.2 17780
4 EX-32.1 lyra-ex32_1.htm EX-32.1 10054
5 EX-32.2 lyra-ex32_2.htm EX-32.2 10043
  Complete submission text file 0000950170-25-064495.txt   9320214

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20250331.xsd EX-101.SCH 1284735
84 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20250331_htm.xml XML 1551800
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 25917506
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)